Adams Helen C. has filed 4 insider transactions across 1 company since May 2024.
Most recent transaction: a grant/award of 33000 shares of Immix Biopharma, Inc. ($IMMX) on June 20, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 20, 2025 | Immix Biopharma, Inc. | $IMMX | Adams Helen C. | Director | A | Stock Option (Right to Buy) | 33000 | $0.00 | 33,000.0000 | 27,722,108 | 9999.99% | 0.12% |
| June 11, 2024 | Immix Biopharma, Inc. | $IMMX | Adams Helen C. | Director | A | Stock Option (Right to Buy) | 33000 | $0.00 | 33,000.0000 | 0 | 9999.99% | 0.00% |
| May 15, 2024 | Immix Biopharma, Inc. | $IMMX | Adams Helen C. | Director | A | Common Stock | 87740 | $0.00 | 100,740.0000 | 0 | 674.92% | 0.00% |
| May 20, 2024 | Immix Biopharma, Inc. | $IMMX | Adams Helen C. | Director | A | Common Stock | 74241 | $0.00 | 174,754.0000 | 0 | 73.86% | 0.00% |